Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Jun 1;181(6):2085–2095. doi: 10.1084/jem.181.6.2085

Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA

PMCID: PMC2192076  PMID: 7760000

Abstract

In comparison with HLA-A and -B, the protein products of the HLA-C locus are poorly characterized, in part because of their low level of expression at the cell surface. Here, we examine how protein-protein interactions during assembly and regulation of the mRNA level affect cell surface expression of HLA-C. We find that intrinsic properties of the HLA-C heavy chain proteins do not correlate with low cell surface expression: HLA-C heavy chains associate and dissociate with beta 2- microglobulin (beta 2m) at rates comparable to those found for HLA-A and -B, and increased competition for beta 2m does not alter the surface expression of HLA-C. From studies of chimeric genes spliced from the HLA-B7 and -Cw3 genes, we find that chimeric proteins containing the B7 peptide-binding groove can have low cell surface expression, suggesting that inefficiency in binding peptides is not the cause of low cell surface expression for HLA-C. The surface levels of HLA-A, -B, or -C in cells transfected with cDNA can be similar, implicating noncoding regions of HLA-C heavy chain genes in the regulation of surface expression. We find that HLA-C mRNA is expressed at lower levels than HLA-B mRNA and that this difference results from faster degradation of the HLA-C message. Experiments examining chimeric B7/Cw3 and B7/Cw6 genes suggest that a region determining low expression of HLA-C is to be found between the 3' end of exon 3 and a site in the 3' untranslated region, approximately 600 bases downstream of the translation stop codon.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M. D., Soares M. B., Kerlavage A. R., Fields C., Venter J. C. Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain cDNA library. Nat Genet. 1993 Aug;4(4):373–380. doi: 10.1038/ng0893-373. [DOI] [PubMed] [Google Scholar]
  2. Barber L. D., Parham P. Peptide binding to major histocompatibility complex molecules. Annu Rev Cell Biol. 1993;9:163–206. doi: 10.1146/annurev.cb.09.110193.001115. [DOI] [PubMed] [Google Scholar]
  3. Belich M. P., Madrigal J. A., Hildebrand W. H., Zemmour J., Williams R. C., Luz R., Petzl-Erler M. L., Parham P. Unusual HLA-B alleles in two tribes of Brazilian Indians. Nature. 1992 May 28;357(6376):326–329. doi: 10.1038/357326a0. [DOI] [PubMed] [Google Scholar]
  4. Bjorkman P. J., Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem. 1990;59:253–288. doi: 10.1146/annurev.bi.59.070190.001345. [DOI] [PubMed] [Google Scholar]
  5. Bodmer J. G., Marsh S. G., Albert E. D., Bodmer W. F., Dupont B., Erlich H. A., Mach B., Mayr W. R., Parham P., Sasazuki T. Nomenclature for factors of the HLA system, 1994. Tissue Antigens. 1994 Jul;44(1):1–18. doi: 10.1111/j.1399-0039.1994.tb02351.x. [DOI] [PubMed] [Google Scholar]
  6. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., Cerami A. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1670–1674. doi: 10.1073/pnas.83.6.1670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Colonna M., Borsellino G., Falco M., Ferrara G. B., Strominger J. L. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12000–12004. doi: 10.1073/pnas.90.24.12000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. D'Alfonso S., Savoia P., Pitti G., Peruccio D., Pozzi C., Crepaldi T., Falda M., Ficara F., Resegotti L., Momigliano Richiardi P. Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells. Eur J Immunogenet. 1993 Jun;20(3):165–173. doi: 10.1111/j.1744-313x.1993.tb00107.x. [DOI] [PubMed] [Google Scholar]
  10. Davidson W. F., Kress M., Khoury G., Jay G. Comparison of HLA class I gene sequences. Derivation of locus-specific oligonucleotide probes specific for HLA-A, HLA-B, and HLA-C genes. J Biol Chem. 1985 Nov 5;260(25):13414–13423. [PubMed] [Google Scholar]
  11. Domena J. D., Little A. M., Arnett K. L., Adams E. J., Marsh S. G., Parham P. A small test of a sequence-based typing method: definition of the B*1520 allele. Tissue Antigens. 1994 Oct;44(4):217–224. doi: 10.1111/j.1399-0039.1994.tb02386.x. [DOI] [PubMed] [Google Scholar]
  12. Domena J. D., Little A. M., Madrigal A. J., Hildebrand W. H., Johnston-Dow L., du Toit E., Bias W. B., Parham P. Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations. Tissue Antigens. 1993 Nov;42(5):509–517. doi: 10.1111/j.1399-0039.1993.tb02196.x. [DOI] [PubMed] [Google Scholar]
  13. Emerson S. G., Murphy D. B., Cone R. E. Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2-restricted recognition. J Exp Med. 1980 Oct 1;152(4):783–795. doi: 10.1084/jem.152.4.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hajek-Rosenmayr A., Jungl L., Stammler M., Kirnbauer M. HLA-C "blank" alleles express class I gene products. Biochemical analysis of four different HLA-C "blank" polypeptides. Immunogenetics. 1989;30(6):399–404. doi: 10.1007/BF02421170. [DOI] [PubMed] [Google Scholar]
  15. Hentze M. W. Determinants and regulation of cytoplasmic mRNA stability in eukaryotic cells. Biochim Biophys Acta. 1991 Nov 11;1090(3):281–292. doi: 10.1016/0167-4781(91)90191-n. [DOI] [PubMed] [Google Scholar]
  16. Hildebrand W. H., Domena J. D., Shen S. Y., Lau M., Terasaki P. I., Bunce M., Marsh S. G., Guttridge M. G., Bias W. B., Parham P. HLA-B15: a widespread and diverse family of HLA-B alleles. Tissue Antigens. 1994 Apr;43(4):209–218. doi: 10.1111/j.1399-0039.1994.tb02327.x. [DOI] [PubMed] [Google Scholar]
  17. Hill A., Takiguchi M., McMichael A. Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain. Immunogenetics. 1993;37(2):95–101. doi: 10.1007/BF00216831. [DOI] [PubMed] [Google Scholar]
  18. Lin A. Y., Devaux B., Green A., Sagerström C., Elliott J. F., Davis M. M. Expression of T cell antigen receptor heterodimers in a lipid-linked form. Science. 1990 Aug 10;249(4969):677–679. doi: 10.1126/science.1696397. [DOI] [PubMed] [Google Scholar]
  19. Madden D. R., Gorga J. C., Strominger J. L., Wiley D. C. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 1992 Sep 18;70(6):1035–1048. doi: 10.1016/0092-8674(92)90252-8. [DOI] [PubMed] [Google Scholar]
  20. McCutcheon J. A., Lutz C. T. Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies. Hum Immunol. 1992 Oct;35(2):125–131. doi: 10.1016/0198-8859(92)90020-n. [DOI] [PubMed] [Google Scholar]
  21. Ming Y. Z., Di X., Gomez-Sanchez E. P., Gomez-Sanchez C. E. Improved downward capillary transfer for blotting of DNA and RNA. Biotechniques. 1994 Jan;16(1):58–59. [PubMed] [Google Scholar]
  22. Neefjes J. J., Ploegh H. L. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol. 1988 May;18(5):801–810. doi: 10.1002/eji.1830180522. [DOI] [PubMed] [Google Scholar]
  23. Parham P., Adams E. J., Arnett K. L. The origins of HLA-A,B,C polymorphism. Immunol Rev. 1995 Feb;143:141–180. doi: 10.1111/j.1600-065x.1995.tb00674.x. [DOI] [PubMed] [Google Scholar]
  24. Saper M. A., Bjorkman P. J., Wiley D. C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol. 1991 May 20;219(2):277–319. doi: 10.1016/0022-2836(91)90567-p. [DOI] [PubMed] [Google Scholar]
  25. Sarkar G., Sommer S. S. The "megaprimer" method of site-directed mutagenesis. Biotechniques. 1990 Apr;8(4):404–407. [PubMed] [Google Scholar]
  26. Shimizu Y., DeMars R. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J Immunol. 1989 May 1;142(9):3320–3328. [PubMed] [Google Scholar]
  27. Shyu A. B., Greenberg M. E., Belasco J. G. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 1989 Jan;3(1):60–72. doi: 10.1101/gad.3.1.60. [DOI] [PubMed] [Google Scholar]
  28. Smith K. D., Valenzuela A., Vigna J. L., Aalbers K., Lutz C. T. Unwanted mutations in PCR mutagenesis: avoiding the predictable. PCR Methods Appl. 1993 Feb;2(3):253–257. doi: 10.1101/gr.2.3.253. [DOI] [PubMed] [Google Scholar]
  29. Snary D., Barnstable C. J., Bodmer W. F., Crumpton M. J. Molecular structure of human histocompatibility antigens: the HLA-C series. Eur J Immunol. 1977 Aug;7(8):580–585. doi: 10.1002/eji.1830070816. [DOI] [PubMed] [Google Scholar]
  30. Sodoyer R., Damotte M., Delovitch T. L., Trucy J., Jordan B. R., Strachan T. Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA-CW3). EMBO J. 1984 Apr;3(4):879–885. doi: 10.1002/j.1460-2075.1984.tb01900.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Steinle A., Nössner E., Schendel D. J. Isolation and characterization of a genomic HLA-Cw6 clone. Tissue Antigens. 1992 Mar;39(3):134–137. doi: 10.1111/j.1399-0039.1992.tb01923.x. [DOI] [PubMed] [Google Scholar]
  32. Strachan T., Sodoyer R., Damotte M., Jordan B. R. Complete nucleotide sequence of a functional class I HLA gene, HLA-A3: implications for the evolution of HLA genes. EMBO J. 1984 Apr;3(4):887–894. doi: 10.1002/j.1460-2075.1984.tb01901.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sugden B., Marsh K., Yates J. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol. 1985 Feb;5(2):410–413. doi: 10.1128/mcb.5.2.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Takebe Y., Seiki M., Fujisawa J., Hoy P., Yokota K., Arai K., Yoshida M., Arai N. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol. 1988 Jan;8(1):466–472. doi: 10.1128/mcb.8.1.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Takiguchi M., Nishimura I., Hayashi H., Karakl S., Kariyone A., Kano K. The structure and expression of genes encoding serologically undetected HLA-C locus antigens. J Immunol. 1989 Aug 15;143(4):1372–1378. [PubMed] [Google Scholar]
  36. Tibensky D., Decary F., Delovitch T. L. HLA-C genes are transcribed in HLA-C blank individuals. Immunogenetics. 1988;27(3):220–224. doi: 10.1007/BF00346590. [DOI] [PubMed] [Google Scholar]
  37. Tibensky D., Delovitch T. L. Promoter region of HLA-C genes: regulatory elements common to and different from those of HLA-A and HLA-B genes. Immunogenetics. 1990;32(3):210–213. doi: 10.1007/BF02114976. [DOI] [PubMed] [Google Scholar]
  38. Trinchieri G. Recognition of major histocompatibility complex class I antigens by natural killer cells. J Exp Med. 1994 Aug 1;180(2):417–421. doi: 10.1084/jem.180.2.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Turner M. J., Strominger J. L., Sanderson A. R. Enzymic removal and re-expression of a histocompatibility antigen, HL-A 2, at the surface of human peripheral lymphocytes ( 31 Cr-labeled cells-papain-puromycin-actinomycin D). Proc Natl Acad Sci U S A. 1972 Jan;69(1):200–202. doi: 10.1073/pnas.69.1.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Versteeg R., Krüse-Wolters K. M., Plomp A. C., van Leeuwen A., Stam N. J., Ploegh H. L., Ruiter D. J., Schrier P. I. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J Exp Med. 1989 Sep 1;170(3):621–635. doi: 10.1084/jem.170.3.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ways J. P., Parham P. The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2. Biochem J. 1983 Nov 15;216(2):423–432. doi: 10.1042/bj2160423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wesley P. K., Clayberger C., Lyu S. C., Krensky A. M. The CD8 coreceptor interaction with the alpha 3 domain of HLA class I is critical to the differentiation of human cytotoxic T-lymphocytes specific for HLA-A2 and HLA-Cw4. Hum Immunol. 1993 Mar;36(3):149–155. doi: 10.1016/0198-8859(93)90118-k. [DOI] [PubMed] [Google Scholar]
  43. Wisdom R., Lee W. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 1991 Feb;5(2):232–243. doi: 10.1101/gad.5.2.232. [DOI] [PubMed] [Google Scholar]
  44. Yang S. Y., Morishima Y., Collins N. H., Alton T., Pollack M. S., Yunis E. J., Dupont B. Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics. 1984;19(3):217–231. doi: 10.1007/BF00364765. [DOI] [PubMed] [Google Scholar]
  45. Zemmour J., Little A. M., Schendel D. J., Parham P. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol. 1992 Mar 15;148(6):1941–1948. [PubMed] [Google Scholar]
  46. Zemmour J., Parham P. Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J Exp Med. 1992 Oct 1;176(4):937–950. doi: 10.1084/jem.176.4.937. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES